A New Weapon Against Cancer, we dive deeper into how this powerful blend of diagnostics and targeted therapy is reshaping oncology. Join experts from Vizient and Sg2 as they explore real-world implementation, future innovations, and why theranostics may soon become standard of care for more cancer types.

What if you could see cancer and treat it—all in one powerful, targeted approach? In this episode of The Capital Compass, host Adam Fairbourn sits down with Lindsay Williams (Vizient), Setu Shah (Sg2), and industry expert Janna Laton to explore theranostics: a groundbreaking fusion of diagnostics and therapy that's transforming cancer care.

Diagnostic imaging is evolving—and so is its footprint on the planet, the workforce, and the communities it serves. In Part 2 of this Capital Compass series, host Andrew Rebhan continues the conversation with Vizient’s Adam Fairbourn and Sg2’s Gurmeet Bawa, diving into the next frontier of imaging strategy.

Imaging is breaking out of the basement—and breaking into the future. In this episode of The Capital Compass, host Andrew Rebhan is joined by Vizient’s Adam Fairbourn and Sg2’s Gurmeet Bawa to explore why diagnostic imaging is becoming a strategic powerhouse in healthcare.